Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the page metadata. This appears to be a minor update to the page instead of a substantive change to the study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows Revision: v3.5.3 instead of v3.5.2, indicating a small internal update; no study information or displayed content has been altered.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.